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Feverfew (Tanacetum parthenium (L.) Schulz Bip., Asteraceae), a medicinal plant with a long tradi-
tion in European folk medicine, has been used to treat headache, fever, rheumatism, asthma, stomach
pains, and other conditions related to inflammation. Although feverfew is often used for migraine
headaches, numerous literature data stated the inconclusiveness regarding its efficacy. Namely, there
is the discrepancy between the stated and the found quantity of the carrier of the mentioned activity
(parthenolide) in the herbal products containing feverfew or its extracts. Based on the EMA mono-
graphs, it is evident that the feverfew phytopreparation might be designed from the raw herbal ma-
terial, adequately prepared. Therefore, in this work we investigated the variation of the parthenolide
content in different parts of this plant during 18 months storage in order to enable the data regarding
the possible use of the powered plants in preparations aimed for migraine prophylaxis. Besides, the
total phenolic compound content was determined, as well. The results revealed that the content of
parthenolide decreased during the investigated period. In contrast, parthenolide content in the com-
mercially available extract did not change during the time of investigation. Different particle size of
the tested drugs in our investigation seemed to influence only total flavonoid content. Total flavonoids
and total phenolics content remained the same during 18 months of storage.




Feverfew (Tanacetum parthenium (L.) Schulz Bip., Asteraceae)
is a medicinal plant with a long tradition in European folk
medicine used in the treatment of fevers, migraine headaches,
rheumatoid arthritis, stomach aches, toothaches, insect bites,
infertility, problems with menstruation and labor, and also
for psoriasis, allergies, asthma, tinnitus, dizziness, nausea,
and vomiting (ABC, 2003; Pareek et al., 2011). Nowadays, it
is widely used in prophylaxis of migraine headaches avail-
able in the market either as fresh, freeze-dried, or dried herb,
or in the form of phytopreparations, such as liquid extracts,
tablets or more commonly - capsules (Pareek et al., 2011).
Stated usage of feverfew in the form of its powdered aerial
parts has been approved by the European Medicines Agency
(EMA) based upon its long-standing use (EMA, 2010). Us-
age of feverfew drugs and/or its preparations in migraine
headaches has been confirmed in several pharmacological
studies and clinical trials. In addition to this, several biologi-
cal properties, such as anti-inflammatory, chemotherapeutic
and anticancer activity, effects on vascular smooth muscle and
platelets, as well as inhibition of histamine release have been
shown for feverfew extracts and/or its isolated compounds
(Pareek et al., 2011). Most of the stated biological activities
of feverfew are attributed to sesquiterpene lactones, among
which parthenolide is considered the most active chemical con-
stituent. Other potentially active constituents are flavonoid
glycosides and pinenes. Also, many components are identi-
fied in the volatile oil which is responsible for the strong and
bitter odor characteristic for the feverfew plant. Aside being
considered the most important biologically active principle
of feverfew, parthenolide is widely used as a marker for stan-
dardization of its extracts and quality control of finished prod-
ucts, as a prerequisite for the development and production
of phytopreparations in accordance with the requests of the
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Table 1. Parthenolide content in different organs of the feverfew (Tanacetum parthenium) during storage in two consecutive years
Plant part Omnipharm
Months folium flos herba herba [> 0.3 mm] herba [< 0.3 mm] extracta
[mg/g] [mg/g] [mg/g] [mg/g] [mg/g] [mg/g]
Year 2015 1st 3.95±0.22 15.78±0.51 5.57±0.30 - - -
6th 3.81±0.21 12.83±0.44 3.76±0.30 - - -
18th 2.39±0.22 11.55±0.60 3.65±0.31 - - -
Year 2016 1st 6.46±0.24 15.84±0.53 9.04±0.30 - - -
6th 6.22±0.22 14.30±0.50 7.24±0.32 6.58±0.12 7.00±0.08 11.66±0.31
18th 3.10±0.20 14.11±0.65 4.39±0.29 3.52±0.12 3.60±0.10 10.64±0.33
a Commercial extract with standardized parthenolide content (1.1%), according to manufacturer’s claims
appropriate regulatory authorities (Kopelman et al., 2008). To
this end, the development of adequate chemical methods for
identification and quantification of active/analytical markers
is an inevitable step in the development and quality assur-
ance of contemporary plant-based preparations not only in
the final formulations but also semi-products and herbal raw
materials. In other words, for the production of high-quality
phytopreparations, herbal drug (substance) of defined quality
is imperative. In this context, the aim of the current study was
to investigate parthenolide content in various herbal drugs of
Tanacetum parthenium (L.) Schulz Bip., Asteraceae i.e. flowers,
leaves and aerial parts, bearing in mind that the content of this
sesquiterpene lactone (not less than 0.20 percent) is defined as
the quality criteria for the feverfew herbal drug (dried, whole
or fragmented aerial parts) in the European Pharmacopoeia
(Ph.Eur.9.0., 2017).
Therefore, parthenolide content in our study was monitored
during the storage period of 18 months. In addition, as the
phenolic constituents are generally accepted as actives with
significant biological properties, total flavonoid (TF) and to-
tal phenolic compounds (TP) content were monitored in the
investigated samples, as well. Also, in order to evaluate the
changes in parthenolide and TF/TP content as a function of
particle size, two additional samples (one being >0.3 mm and
the other being <0.3 mm in diameter) was prepared from aerial
parts of the plants harvested in 2016, taking into considera-
tion that those samples were superior in quality regarding the
monitored parameters in comparison to the ones harvested
during 2015.
The aim of our investigation was to get more insight into the
variation in the percentage of parthenolide content in various
parts of the individual plant. This is important in the light of
standardization and quality of feverfew supplements.
2. MATERIALS AND METHODS
2.1. Plant material
Plant material was obtained from the Institute for Medic-
inal Plant Research “Dr. Josif Pancic” (Serbia) and the
voucher specimen has been stored at Institute’s herbarium,
No. TPA15/06, harvest 2015, and No. TPA16/06, harvest 2016.
Extract of Tanacetum parthenium (L.) Schulz Bip., Asteraceae
was purchased from Omnipharm, France.
2.2. Extraction procedure
The extraction procedure of the plant material was conducted
according to the procedure described in the European Pharma-
copoeia (Ph.Eur.7.0., 2010). One gram of powdered drug was
heated with 40 mL of methanol in a water-bath at 60 °C for
10 min. After cooling the mixture was rinsed with 15 mL of
methanol and filtered. The procedure was repeated with the
residual part. Collected filtrates and rinsings were evaporated
to dryness under reduced pressure. The residual part was
taken up with the methanol and diluted to 20 mL with the
same solvent. After filtration diluted extract was further used
for chemical analysis.
2.3. Determination of total phenolic compounds
Total phenolic (TP) content in the samples was determined
spectrophotometrically using the Folin-Ciocalteu method (Wa-
terman and Mole, 1994). Two hundred microliters of diluted
extracts were added to 1 mL of 1:10 diluted Folin-Ciocalteu
reagent. After 4 min, 800 µL of sodium carbonate (75 g/L) was
added. The absorbance was measured after 2 h of incubation
at room temperature, at 765 nm. Gallic acid (0–100 mg/L)
was used for calibration of a standard curve. The results were
expressed as milligrams of gallic acid equivalents per gram
of dry weight of fraction (mg GAE/g DW). All experiments
were repeated three times.
2.4. Determination of total flavonoids
The total flavonoids content (TF) in tested samples was de-
termined using a modified colorimetric assay previously de-
scribed by Loizzo et al. (2012). Properly diluted extract (200
µL) was mixed with 60% ethanol (800 µL) and 5% sodium
nitrite solution (60 µL). After 5 min, 10% aluminum chloride
solution (600 µL) was added and after 6 min 1 M sodium hy-
droxide solution (400 µL), and the mixture was adjusted to
2 mL with deionized water. The absorbance was measured
at 510 nm against the blank (all reagents except the extract).
Catechin monohydrate was used to calculate the calibration
curve (0.05–0.3 g/L), and results were expressed as milligrams
of catechin equivalents per liter of extract (mg CE/L). All
experiments were repeated three times.
2.5. HPLC analysis
Analyses were carried out on Agilent 1200 RR HPLC instru-
ment (Agilent, Waldbronn, Germany), with DAD detector,
on a reverse-phase LiChrospher (Agilent) analytical column
(250 mm × 4 mm i.d.; 5 µm particle size). Isocratic elution
was applied and mixture of acetonitrile and water (55:45, v/v)
was used as a mobile phase. Stop time of the analysis was 10
min. Detection wavelength was set at 210 nm, and the flow
rate was 1 mL/min. The injection volume was 10 µL and the
column temperature was maintained at 25 °C. The identifica-
tion of parthenolide was based on comparison of retention
time and UV spectra with those from the authentic standard
while its amount was calculated using calibration curve. The
results are presented as milligrams per gram of dry weight.
All experiments were repeated three times.
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Fig. 1. HPLC chromatograms of investigated samples and standard recorded at λ = 210 nm: A) parthenolide standard; B) Tanaceti parthenii
folium - 2015 (sample diluted 2 times before injection); C) Tanaceti parthenii flos – 2015 (sample diluted 3 times before injection); D) Tanaceti
parthenii herba - 2015 (non-diluted sample)
3. RESULTS AND DISCUSSION
Herbal product’s quality is dependent on the content of bio-
logically active constituents present in the herb. The sesquiter-
pene lactone parthenolide is identified as one of the com-
pounds for some of feverfew’s beneficial effects (Benassi-
Zanqueta et al., 2018). Beside maceration, several other tech-
niques have been used for its extraction such as Soxhlet and
bottle stirring (Zhou et al., 1999), high-pressure extraction
with CO2 (Cˇretnik et al., 2005; Kery et al., 1999) and extraction
under vacuum (Marete et al., 2009). Also, various extraction
solvents were applied. They usually included chloroform
(Marchand et al., 1983), petroleum ether (Awang et al., 1991),
acetone (Heptinstall et al., 1992) and acetonitrile (Abourashed
et al., 2000). Wu et al. (2006) extracted parthenolide, luteolin,
apigenin from feverfew in 80% alcohol, while Marete et al.
(2009) applied distilled water heated at various temperatures.
Physiochemical methods were used for parthenolide quantifi-
cation in several commercial products with T. parthenium. The
results varied significantly and, in some products, partheno-
lide was not detected (Ghafari et al., 2010).
According to our results (Table 1, Figure 1) there is a wide
variation in the amount of parthenolide in different parts of
the herb. The highest content was recorded in flower samples
(15.78 mg/g), while the lowest level was detected in leaf sam-
ples (3.95 mg/g). This is in accordance with previous studies.
Heptinstall et al. (1992) showed that the highest content of
parthenolide was found in flower heads (138 mg/100 g of
raw material), followed by leaves (95 mg/100 g of raw mate-
rial), and with only 80 mg/100 g raw material in stalks and
10 mg/100 raw material in roots. Similarly, Majdi et al. (2011)
exhibited that the highest amount of parthenolide in flower
heads, while no parthenolide was detected in feverfew roots.
The same group of authors showed that the parthenolide con-
tent varied significantly between the two components of the
flower. The highest amount was found in the disc florets when
compared with the ray floret and this fact corresponded to a
higher density of glandular trichome on the disc florets.
During the period of 18 months, while the investigated sam-
ples were stored and kept under storage conditions mimicking
the usual manner of keeping the plant raw material (leaves,
flowers and herbs) and dry extracts, adopting the manag-
ing quality to prevent degradation, contamination, and cross-
contamination, in appropriate containers, it could be observed
that in the extract commercially available at the market the
parthenolide content decreased less than 0.1%, in contrast to
the investigated T. parthenii drugs (leaves, flowers and aerial
parts), in which a greater percentage of parthenolide content
decrease was noticed (Table 1).
Regarding leaves, Végh et al. (2014) demonstrated that the
highest content of parthenolide was found in leaves collected
before flowering compared to the leaves collected during the
flowering period. That implies that with the beginning of
the flowering period a decrease of parthenolide contents in
the leaves arises. Parthenolide level can also decline during
storage (Heptinstall et al., 1992). This has also been confirmed
in our results (Table 1). The particle size of powdered samples
is a significant factor that could affect the content of bioactive
constituents. Parthenolide could be located in trichomes or
bonded densely in other tissues. These various locations can
potentially demonstrate the significance of obtaining finely
grounded samples for maximum extraction yields (Fonseca
et al., 2006). According to this group of authors parthenolide
extraction from unsieved samples was higher compared to
extraction from 1000-500 µm particle size and lower compared
to parthenolide content obtained from samples of <500 µm
particle size. From our results presented in Table 1, it can
be seen that slightly greater content of parthenolide was ob-
tained in herb samples with particle size lower than 0.3 mm
in comparison to the higher one.
European Pharmacopoeia (Ph.Eur.7.0., 2010) requires mini-
mum 0.2% of parthenolide content for T. parthenium aerial part.
According to our results, for all of the investigated samples
this condition was met. Even though the flower heads might
contain more than 1.0% of parthenolide, which is in accor-
dance to our results as well (Table 1) it was not convenient to
establish T. parthenii flowers as an independent phytothera-
peutic drug, since the yield of flower heads was fairly small
(about 20% related to the whole drug) (Hendricks et al., 1997).
In addition, taking into account that the presence of
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Table 2. Total flavonoid content in different organs of the feverfew (Tanacetum parthenium) during storage in two consecutive years
Plant part Omnipharm
Months folium flos herba herba [> 0.3 mm] herba [< 0.3 mm] extracta
[mgCatE/g] [mgCatE/g] [mgCatE/g] [mgCatE/g] [mgCatE/g] [mgCatE/g]
Year 2015 1st 863.6±38.1 315.0±25.1 292.7±23.1 - - -
6th 855.7±36.2 315.0±25.1 290.7±25.1 - - -
18th 855.4±38.2 313.9±22.9 290.7±25.1 - - -
Year 2016 1st 697.6±32.4 340.2±25.8 336.9±25.1 436.3±33.2 665.7±35.6 670.9±36.1
6th 690.6±31.5 340.0±25.8 332.5±29.1 430.7±37.1 662.3±35.1 667.2±35.9
18th 690.6±38.1 339.7±22.7 332.1±29.1 430.2±35.9 661.9±35.1 666.5±35.8
a Commercial extract with standardized parthenolide content (1.1%), according to manufacturer’s claims
Table 3. Total phenolis content in different organs of the feverfew (Tanacetum parthenium) during storage in two consecutive years
Plant part Omnipharm
Months folium flos herba herba [> 0.3 mm] herba [< 0.3 mm] extracta
[mgGAE/g] [mgGAE/g] [mgGAE/g] [mgGAE/g] [mgGAE/g] [mgGAE/g]
Year 2015 1st 14.9±2.0 12.5±1.1 11.5±1.1 - - -
6th 14.7±1.3 12.1±1.5 11.2±0.9 - - -
18th 14.4±1.3 11.9±1.5 11.2±1.3 - - -
Year 2016 1st 17.7±1.0 10.9±0.9 15.2±2.3 18.3±2.2 15.9±2.1 55.2±2.5
6th 17.6±1.5 10.9±1.1 15.2±2.3 18.1±2.5 15.5±1.9 55.1±2.1
18th 17.5±1.5 10.7±1.3 15.0±2.3 18.0±2.5 15.5±2.1 55.0±2.5
a Commercial extract with standardized parthenolide content (1.1%), according to manufacturer’s claims
flavonoids and phenolic compounds might significantly affect
the overall activity of the phytopreparations, we monitored
their amount in the tested samples during the investigated
period of time. It was noticed that their content was lower in
comparison to data reported in the literature (Wu et al., 2006).
Our results revealed that TF and TP content did not decrease
significantly over the 18-months period (Tables 2 and 3).
CONCLUSION
The results of our study revealed that the content of partheno-
lide decreased during the investigated period (from 3.95 to
2.39, from 15.78 to 12.83 and from 5.57 to 3.65 mg partheno-
lide/g of the samples (leaves, flowers and aerial part, respec-
tively), obtained during the harvest 2015, and from 6.46 to
3.10, from 15.84 to 14.11, from 9.04 to 4.39 mg parthenolide/g
of the samples (leaves, flowers and aerial part, respectively),
obtained during the harvest 2016). In contrast, parthenolide
content in the commercially available extract did not change
during the time of the investigation. Different particle size of
the tested drugs in our investigation seemed to influence only
total flavonoids content. Total flavonoids and total phenolics
content remained the same during 18 months of storage.
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